![Morphic Holding Inc](/common/images/company/N_MORF.png)
Morphic Holding Inc is a biopharmaceutical company applying its insights into integrins to discover and develop a pipeline of oral small-molecule integrin therapeutics. Integrins are a target class with multiple approved injectable blockbuster drugs for the treatment of serious chronic diseases, inc... Morphic Holding Inc is a biopharmaceutical company applying its insights into integrins to discover and develop a pipeline of oral small-molecule integrin therapeutics. Integrins are a target class with multiple approved injectable blockbuster drugs for the treatment of serious chronic diseases, including autoimmune, cardiovascular, and metabolic diseases, fibrosis, and cancer. Show more
Kuehn Law Encourages MORF, PFC, WSBC, and ACNB Investors to Contact Law Firm PR Newswire NEW YORK, July 31, 2024 NEW YORK, July 31, 2024 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation...
BP plc (NYSE:BP) – BP expects weak margins in its refining business to impact its second-quarter profits by up to $700 million. The decline in refining margins, due to excess renewable...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.15 | 0.265439745178 | 56.51 | 56.78 | 56.43 | 1459672 | 56.62514353 | CS |
4 | 25.08 | 79.4173527549 | 31.58 | 56.78 | 31.01 | 5735920 | 55.78474422 | CS |
12 | 26.99 | 90.9673070442 | 29.67 | 56.78 | 25.25 | 2304681 | 51.48353764 | CS |
26 | 25.74 | 83.2470892626 | 30.92 | 56.78 | 25.25 | 1312292 | 47.9439288 | CS |
52 | 1.16 | 2.09009009009 | 55.5 | 62.08 | 19.345 | 1063176 | 40.5707697 | CS |
156 | -0.75 | -1.30639261453 | 57.41 | 68.75 | 19.23 | 574848 | 40.47025737 | CS |
260 | 35.81 | 171.75059952 | 20.85 | 93 | 9.9 | 398751 | 41.37426386 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.